David Elsley, the President & CEO of Cardiol Therapeutics Inc. (Nasdaq: CRDL | TSX: CRDL), a company dedicated to healing the heart with innovative science, joins Vince Molinari to discuss their recent milestones to kick off 2024. Mr. Elsley shares the significance of Cardiol receiving the US FDA grant for Orphan Drug Designation for the company's lead drug candidate, CardiolRx™, aimed at treating pericarditis, including recurrent pericarditis. He speaks to the severity of recurrent pericarditis, characterized by symptoms that significantly impact patients' quality of life and physical activity. The FDA's decision to grant ODD underscores the potential of CardiolRx™ to improve the lives of individuals suffering from this condition. They discuss Cardiol's two ongoing Phase II clinical trials targeting rare diseases of recurrent pericarditis and acute myocarditis. Additionally, Mr. Elsley shares the market opportunity for the company’s potential treatment for heart failure – a leading cause of death and hospitalization in the developed world, with associated healthcare costs in the United States exceeding $30 billion annually.
Todd McDonald, Co-Founder and Chief Strategy Officer at R3, joins Remy Blaire to discuss understanding tokenization and real-world assets on the blockchain.
John Schaible, Chief Strategy Officer at AtlasClear Holdings, inc., joins Vince Molinari to discuss ringing the opening bell and the future of the company. Atlas Clear aims to create a more efficient platform for trading, and banking.
Michael Reinking, Senior Market Strategist at the NYSE, provides insight into the U.S. inflation data and jobs report. Ahead of the March FOMC meeting, Reinking weighs in on event risk on the horizon.
Michael Warshowsky, CEO & Founder of Belay, joins Remy Blaire to discuss Belay. Belay was developed to help everyday traders protect their investments in the stock market.
Brian Foote, Chief Executive Officer of HUMBL, and Lawrence Wintermeyer, Chief Executive Officer of Avrio, join Remy Blaire to discuss Avrio's acquisition of HUMBL Financial.
Ilan Sobel, Co-Founder and CEO of BioHarvest Sciences, joins Remy Blaire to discuss plant cell biology and BioHarvest Sciences launching contract development and manufacturing organization unit.
Michael Reinking, Senior Market Strategist at the NYSE, provides an overview of U.S. equity market performance as the final month of Q1 2024 gets underway. Ahead of key event risk, tailwinds from uncertainty around the Fed's interest rate trajectory are considered.
Big news from the floor of the NYSE. Roberts and Ryan Inc., a veteran-owned broker-dealer, has achieved a major milestone by joining the New York Stock Exchange.
Rich "Big Daddy" Salgado, Chief Communications Officer at Gas It Up and CEO of Coastal Advisors, LLC Consultants, joins Vince Molinari to discuss Rich's entrepreneurial journey.
Shubha Dasgupta, Co-Founder and CEO of Pineapple, joins Remy Blaire to discuss Pineapple's goal and vision for the space in Canada. They also analyze Pineapple's IPO journey.